NEWARK, DE | The global Heart Failure Biomarker Market is projected to expand from USD 2,400.0 million in 2026 to USD 5,200.0 million by 2036, registering a CAGR of 8.0% over the forecast period. Growth is being driven by increasing adoption of biomarker-based diagnostics in emergency and inpatient care pathways, where rapid clinical decision-making is critical. The Heart...